NCT02037542

Brief Summary

The purpose of this study is to test the hypothesis that an intervention of lifestyle modification will positively impact women with breast cancer who are overweight and/or obese. To that end, our primary endpoint is to examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2013

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 16, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

July 21, 2016

Status Verified

July 1, 2016

Enrollment Period

2.7 years

First QC Date

July 16, 2013

Last Update Submit

July 20, 2016

Conditions

Keywords

BMI, Lipid profile

Outcome Measures

Primary Outcomes (1)

  • Lifestyle intervention

    To examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.

    One year

Secondary Outcomes (1)

  • Lipid Profiles, hemoglobin A1C

    1 year

Study Arms (1)

Diet and Exercise

EXPERIMENTAL

Prospective, observational, cohort study, with a proposed start date of May 2013 and proposed end date of June 2018. Our goal is to gather data on a total of 200 patients: 100 patients (study group) will be prospectively enrolled, while data on another 100 patients (control) will be accessed through retrospective data collection. Number of patients to be analyzed will depend on enrollment and patient compliance. We would like to enroll the proposed 100 patients in the first 1-3 years of the study (approximately 30 per year).

Behavioral: Diet and exercise

Interventions

Upon enrollment, the patient will be asked to meet with a dietitian to assess the individual patient's current diet and exercise routines. In the first session, the dietitian will provide individual counseling and together with the patient devise weight loss / exercise strategies that fit the patients' lifestyle. Following the initial assessment, patients will embark on a weekly program, with weekly meetings lasting 30min - 1h. Patients will be asked to record meal portions weekly in a Food Log (Appendix B), according to the established goal. At each meeting, the dietitian will review the Food Log with the patient and evaluate progress.

Diet and Exercise

Eligibility Criteria

Age18 Years - 89 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DCIS
  • Women with stage 0 - III breast cancer (histologic type ductal or lobular)
  • BMI \>=25
  • Patients must have completed all chemotherapy
  • Patients may be on hormonal therapy or radiation therapy
  • Age \>= 18 years old to 89 Years old
  • Patient must be medically stable and without significant impairments that would preclude following the proposed intervention regimen.
  • Time of diagnosis: patients enrolled are within 1 month to 18 months post-diagnosis.

You may not qualify if:

  • Metastatic breast cancer patients and patients with inoperable or active loco-regional disease.
  • Patients following alternative/complementary diets or taking high dose antioxidant supplements.
  • Patients with a physical/psychiatric impairment that would seriously impair their physical mobility.
  • Patients who are currently suffering from severe nausea, anorexia or other diseases affecting health (e.g. arthritis and multiple sclerosis).
  • Patients younger than 18 and older than 89 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Miami Hospital

Miami, Florida, 33143, United States

Location

Related Publications (3)

  • Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76. doi: 10.1093/jnci/djg060.

    PMID: 14519753BACKGROUND
  • Christy SM, Mosher CE, Sloane R, Snyder DC, Lobach DF, Demark-Wahnefried W. Long-term dietary outcomes of the FRESH START intervention for breast and prostate cancer survivors. J Am Diet Assoc. 2011 Dec;111(12):1844-51. doi: 10.1016/j.jada.2011.09.013.

    PMID: 22117660BACKGROUND
  • Demark-Wahnefried W, Morey MC, Sloane R, Snyder DC, Miller PE, Hartman TJ, Cohen HJ. Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors. J Clin Oncol. 2012 Jul 1;30(19):2354-61. doi: 10.1200/JCO.2011.40.0895. Epub 2012 May 21.

    PMID: 22614994BACKGROUND

MeSH Terms

Conditions

Body Weight

Interventions

DietExercise

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Maria Amelia Rodrigues, MD

    BHSF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research Administrator

Study Record Dates

First Submitted

July 16, 2013

First Posted

January 16, 2014

Study Start

September 1, 2013

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

July 21, 2016

Record last verified: 2016-07

Locations